Atlas Trials

Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.

Clinical trial NCT04912011 · UNKNOWN

Trial details

NCT number
NCT04912011
Sponsor
Pomeranian Medical University Szczecin
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19 Pneumonia
Start date
2021-01-01
Primary completion
2021-08-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.